Exact Mass: 432.1632
Exact Mass Matches: 432.1632
Found 500 metabolites which its exact mass value is equals to given mass value 432.1632
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
salvinorin A
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens A natural product found in Salvia divinorum.
Zizybeoside I
Zizybeoside I is found in fruits. Zizybeoside I is isolated from Zizyphus jujuba (Chinese date Isolated from Zizyphus jujuba (Chinese date). Zizybeoside I is found in fruits.
Melledonal A
Melledonal A is found in mushrooms. Melledonal A is produced by Armillaria mellea (honey mushroom Production by Armillaria mellea (honey mushroom). Melledonal A is found in mushrooms.
Armillaricin
Armillaricin is found in mushrooms. Armillaricin is a metabolite of Armillaria mellea (honey mushroom). Metabolite of Armillaria mellea (honey mushroom). Armillaricin is found in mushrooms.
(2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-yl 4-acetate
(2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-yl 4-acetate is found in herbs and spices. (2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-yl 4-acetate is a constituent of Zingiber officinale (ginger) Constituent of Zingiber officinale (ginger). (2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-yl 4-acetate is found in herbs and spices.
Benzyl gentiobioside
Benzyl gentiobioside is found in garden tomato. Benzyl gentiobioside is a constituent of tomato cell cultures (Lycopersicon esculentum Solanaceae). Constituent of tomato cell cultures (Lycopersicon esculentum Solanaceae). Benzyl gentiobioside is found in garden tomato.
15beta-hydroxycyproterone acetate
15beta-hydroxycyproterone acetate is a metabolite of cyproterone. Cyproterone is a steroidal antiandrogen which was never marketed. An acylated derivative, cyproterone acetate, is widely used clinically used as an antiandrogen and progestin. While cyproterone is sometimes used as a synonym for cyproterone acetate, what is almost always being referred to is actually cyproterone acetate and not cyproterone. (Wikipedia)
Pseudolaric acid-B
12-Epi-Salvinorin A
Ilepatril
N,N-Dimethyl-5-({2-Methyl-6-[(5-Methylpyrazin-2-Yl)carbamoyl]-1-Benzofuran-4-Yl}oxy)pyrimidine-2-Carboxamide
pseudolaric acid B
Pseudolaric acid B is a diterpene lactone. CID 71307573 is a natural product found in Pseudolarix amabilis and Larix kaempferi with data available. Pseudolaric Acid B is a diterpene isolated from the root of Pseudolarix kaempferi (pinaceae), has anti-cancer, antifungal, and antifertile activities, and shows immunosuppressive activity on T lymphocytes[1][2][3]. Pseudolaric Acid B inhibits hepatitis B virus (HBV) secretion through apoptosis and cell cycle arrest. Pseudolaric Acid B induces autophagy[4][5]. Pseudolaric Acid B is a diterpene isolated from the root of Pseudolarix kaempferi (pinaceae), has anti-cancer, antifungal, and antifertile activities, and shows immunosuppressive activity on T lymphocytes[1][2][3]. Pseudolaric Acid B inhibits hepatitis B virus (HBV) secretion through apoptosis and cell cycle arrest. Pseudolaric Acid B induces autophagy[4][5].
Pseudolaric
Pseudolaric acid B is a diterpene lactone. CID 71307573 is a natural product found in Pseudolarix amabilis and Larix kaempferi with data available. Pseudolaric Acid B is a diterpene isolated from the root of Pseudolarix kaempferi (pinaceae), has anti-cancer, antifungal, and antifertile activities, and shows immunosuppressive activity on T lymphocytes[1][2][3]. Pseudolaric Acid B inhibits hepatitis B virus (HBV) secretion through apoptosis and cell cycle arrest. Pseudolaric Acid B induces autophagy[4][5]. Pseudolaric Acid B is a diterpene isolated from the root of Pseudolarix kaempferi (pinaceae), has anti-cancer, antifungal, and antifertile activities, and shows immunosuppressive activity on T lymphocytes[1][2][3]. Pseudolaric Acid B inhibits hepatitis B virus (HBV) secretion through apoptosis and cell cycle arrest. Pseudolaric Acid B induces autophagy[4][5].
Osmanthuside H
Artocommunol CA
Methyltetrapterol A
[3aR-(3aalpha,4alpha,6beta,8alpha,8aalpha,9aalpha)]- 6,8-bis(Acetyloxy)-2,3,3a,4,6,7,8,8a,9,9a-decahydro-5,8a-dimethyl-3-methylene-2-oxonaphtho[2,3-b]furan-4-yl ester 2-methyl-2-propenoic acid
(2R,3S,4S,5R,6R)-5-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-(hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4-diol
[5-(3,4-Dimethoxyphenyl)-4-(hydroxymethyl)tetrahydrofuran-3-yl](3,4,5-trimethoxyphenyl)methanone
(+)-(7alpha,7alpha,8alpha, 8alpha)-3,4,4,5,5-pentamethoxy-7,9: 7,9-diepoxylignan-3-ol|(+)-(7S,7S,8R,8R)-3,4,4,5,5-pentamethoxy-7,9: 7,9-diepoxylignan-3-ol|2,3-dimethoxy-5-{(1S,3aR,4S,6aR)-tetrahydro-4-(3,4,5-trimethoxyphenyl)-1H,3H-furo[3,4-c]furan-1-yl}phenol
2-Methoxy-4-methylphenyl O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
Phenyl ethanol 4-O-??-D-xylopyranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside
rel-(7S,8R,1R,2R,3S,4S)-Delta8-4-acetoxy-2-hydroxy-3,3-dimethoxy-4,5-methylenedioxy-1,2,3,4,5,6-hexahydro-5-oxo-7.3,8.1-neolignan
tyrosol 1-O-beta-D-xylopyranosyl-(1->6)-O-beta-D-glucopyranoside
2-{4-[O-alpha-apiofuranosyl-(1->6)-beta-D-glucopyranosyloxy]phenyl}ethanol
9beta-isobutyryloxyhelenalin-<4-hydroxymethacrylate>
1H,3H-Furo[3,4-c]furan, phenol deriv.; 2,6-Dimethoxy-4-[(1S,3aR,4S,6aR)-tetrahydro-4-(3,4,5-trimethoxyphenyl)-1H,3H-furo[3,4-c]furan-1-yl]phenol
3-methoxyphenol 1-O-alpha-L-rhamnopyranosyl-(1?6)-O-beta-D-glucopyranoside
(-)-hernolactone|(2R,3R)-3-(4-hydroxy-3,5-dimethoxybenzyl)-2-(3,4.5-trimethoxybenzyl)-gamma-butyrolactone
Flavaspidic acid PB
A polyphenol that is a phloroglucinol derivative isolated from the rhizomes of Dryopteris crassirhizoma and has been shown to exhibit radical scavenging and antibacterial activity.
2-C-methyl-D-erythritol 1-O-beta-D-(6-O-4-methoxybenzoyl)glucopyranoside|2-C-methyl-D-erythritol 1-O-[6-O-(4-methoxybenzoyl)-beta-D-glucopyranoside]|2-C-Methyl-D-erythritol 1-O-??-D-(6-O-4-methoxybenzoyl)glucopyranoside
2-methyl-3-[(3,4,5-trimethoxyphenyl)(4-hydroxy-3,5-dimethoxyphenyl)methyl]butyrolactone
rel-(7R,8S,7S,8S)-9-hydroxy-4,5-methylenedioxy-3,4,5,3-tetramethoxy-7,7-epoxylignan
1-[3-[[2,4-dihydroxy-6-methoxy-5-methyl-3-(1-oxopropyl)phenyl]methyl]-2,4,6-trihydroxy-5-methylphenyl]-1-butanone
3-[(3,4,5-Trimethoxyphenyl)methyl]-4-[(7-methoxy-1,3-benzodioxole-5-yl)methyl]tetrahydrofuran-2-ol
1-[2,6-dihydroxy-4-methoxy-3-methyl-5-[[2,4,6-trihydroxy-3-methyl-5-(1-oxopropyl)-phenyl]methyl]phenyl]-1-butanone
(2R,3S,4S,5R,6R)-2-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4,5-triol
[5-acetyloxy-1,7-bis(3,4-dihydroxyphenyl)heptan-3-yl] acetate
C19H28O11_beta-D-Glucopyranoside, 2-(4-hydroxyphenyl)ethyl 2-O-[(2S,3R,4R)-tetrahydro-3,4-dihydroxy-4-(hydroxymethyl)-2-furanyl]
C19H28O11_Benzyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
Ilepatril
CONFIDENCE standard compound; INTERNAL_ID 1338; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4207; ORIGINAL_PRECURSOR_SCAN_NO 4205 C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent CONFIDENCE standard compound; INTERNAL_ID 1338; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4238; ORIGINAL_PRECURSOR_SCAN_NO 4236 CONFIDENCE standard compound; INTERNAL_ID 1338; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4229; ORIGINAL_PRECURSOR_SCAN_NO 4226 CONFIDENCE standard compound; INTERNAL_ID 1338; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4224; ORIGINAL_PRECURSOR_SCAN_NO 4221 CONFIDENCE standard compound; INTERNAL_ID 1338; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4237; ORIGINAL_PRECURSOR_SCAN_NO 4235 CONFIDENCE standard compound; INTERNAL_ID 1338; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8771; ORIGINAL_PRECURSOR_SCAN_NO 8768 CONFIDENCE standard compound; INTERNAL_ID 1338; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8784; ORIGINAL_PRECURSOR_SCAN_NO 8782 CONFIDENCE standard compound; INTERNAL_ID 1338; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8787; ORIGINAL_PRECURSOR_SCAN_NO 8785 CONFIDENCE standard compound; INTERNAL_ID 1338; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8812; ORIGINAL_PRECURSOR_SCAN_NO 8809 CONFIDENCE standard compound; INTERNAL_ID 1338; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8809; ORIGINAL_PRECURSOR_SCAN_NO 8804 CONFIDENCE standard compound; INTERNAL_ID 1338; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8820; ORIGINAL_PRECURSOR_SCAN_NO 8818
(2R,3S,4S,5R,6R)-5-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-(hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4-diol_major
Ala Asp Met Pro
Ala Asp Asn Asn
Ala Asp Pro Met
Ala Met Asp Pro
Ala Met Pro Asp
Ala Asn Asp Asn
Ala Asn Asn Asp
Ala Pro Asp Met
Ala Pro Met Asp
Cys Asp Pro Val
Cys Asp Val Pro
Cys Pro Asp Val
Cys Pro Val Asp
Cys Val Asp Pro
Cys Val Pro Asp
Asp Ala Met Pro
Asp Ala Asn Asn
Asp Ala Pro Met
Asp Cys Pro Val
Asp Cys Val Pro
Asp Asp Pro Ser
Asp Asp Ser Pro
Asp Gly Asn Gln
Asp Gly Gln Asn
Asp Met Ala Pro
Asp Met Pro Ala
Asp Asn Ala Asn
Asp Asn Gly Gln
Asp Asn Asn Ala
Asp Asn Gln Gly
Asp Pro Ala Met
Asp Pro Cys Val
Asp Pro Asp Ser
Asp Pro Met Ala
Asp Pro Ser Asp
Asp Pro Val Cys
Asp Gln Gly Asn
Asp Gln Asn Gly
Asp Ser Asp Pro
Asp Ser Pro Asp
Asp Val Cys Pro
Asp Val Pro Cys
Glu Gly Met Pro
Glu Gly Asn Asn
Glu Gly Pro Met
Glu Met Gly Pro
Glu Met Pro Gly
Glu Asn Gly Asn
Glu Asn Asn Gly
Glu Pro Gly Met
Glu Pro Met Gly
Gly Asp Asn Gln
Gly Asp Gln Asn
Gly Glu Met Pro
Gly Glu Asn Asn
Gly Glu Pro Met
Gly Gly His Tyr
Gly Gly Asn Trp
Gly Gly Trp Asn
Gly Gly Tyr His
Gly His Gly Tyr
Gly His Tyr Gly
Gly Met Glu Pro
Gly Met Pro Glu
Gly Asn Asp Gln
Gly Asn Glu Asn
Gly Asn Gly Trp
Gly Asn Asn Glu
Gly Asn Gln Asp
Gly Asn Trp Gly
Gly Pro Glu Met
Gly Pro Met Glu
Gly Gln Asp Asn
Gly Gln Asn Asp
Gly Trp Gly Asn
Gly Trp Asn Gly
Gly Tyr Gly His
Gly Tyr His Gly
His Gly Gly Tyr
His Gly Tyr Gly
His Tyr Gly Gly
Met Ala Asp Pro
Met Ala Pro Asp
Met Asp Ala Pro
Met Asp Pro Ala
Met Glu Gly Pro
Met Glu Pro Gly
Met Gly Glu Pro
Met Gly Pro Glu
Met Pro Ala Asp
Met Pro Asp Ala
Met Pro Glu Gly
Met Pro Gly Glu
Asn Ala Asp Asn
Asn Ala Asn Asp
Asn Asp Ala Asn
Asn Asp Gly Gln
Asn Asp Asn Ala
Asn Asp Gln Gly
Asn Glu Gly Asn
Asn Glu Asn Gly
Asn Gly Asp Gln
Asn Gly Glu Asn
Asn Gly Gly Trp
Asn Gly Asn Glu
Asn Gly Gln Asp
Asn Gly Trp Gly
Asn Asn Ala Asp
Asn Asn Asp Ala
Asn Asn Glu Gly
Asn Asn Gly Glu
Asn Gln Asp Gly
Asn Gln Gly Asp
Asn Trp Gly Gly
Pro Ala Asp Met
Pro Ala Met Asp
Pro Cys Asp Val
Pro Cys Val Asp
Pro Asp Ala Met
Pro Asp Cys Val
Pro Asp Asp Ser
Pro Asp Met Ala
Pro Asp Ser Asp
Pro Asp Val Cys
Pro Glu Gly Met
Pro Glu Met Gly
Pro Gly Glu Met
Pro Gly Met Glu
Pro Met Ala Asp
Pro Met Asp Ala
Pro Met Glu Gly
Pro Met Gly Glu
Pro Ser Asp Asp
Pro Val Cys Asp
Pro Val Asp Cys
Gln Asp Gly Asn
Gln Asp Asn Gly
Gln Gly Asp Asn
Gln Gly Asn Asp
Gln Asn Asp Gly
Gln Asn Gly Asp
Ser Asp Asp Pro
Ser Asp Pro Asp
Ser Pro Asp Asp
Val Cys Asp Pro
Val Cys Pro Asp
Val Asp Cys Pro
Val Asp Pro Cys
Val Pro Cys Asp
Val Pro Asp Cys
Trp Gly Gly Asn
Trp Gly Asn Gly
Trp Asn Gly Gly
Tyr Gly Gly His
Tyr Gly His Gly
Tyr His Gly Gly
2-(3,4-dihydroxy-5-methoxyphenyl)-6-[2-(4-hydroxy-3-methoxyphenyl)ethyl]oxan-4-yl acetate
Melledonal
Armillaricin
Benzyl gentiobioside
Darendoside A
Benzoic acid, 4-(5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo-, 2-phenoxyethyl ester
2-((Benzoyloxy)methyl)-2-methyldibenzoate-1,3-propanediol
1-(4-methoxyphenyl)-7,7-dimethyl-3-[(3-nitrophenyl)methyl]-6,8-dihydroquinoline-2,5-dione
bis(prop-2-enyl) benzene-1,2-dicarboxylate,2-methylidenebutanoic acid,2-methylprop-2-enoic acid
3-[4-(3-methylsulfinyl-11-oxo-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazin-1-yl]propan-1-ol
1-BOC-4-(2-(4-FLUORO-3-(TRIFLUOROMETHYL)PHENYL)-2-OXOETHYLCARBAMOYL)PIPERIDINE
[2-[1-(TRIPHENYLMETHYL)-1H-TETRAZOL-5-YL]PHENYL]BORONIC ACID
Timolol maleate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents (S)-Timolol Maleate (L-714,465 Maleate) is a non-cardioselective hydrophilic β-adrenoceptor blocker. (S)-Timolol Maleate is widely used as standard medication for intraocular pressure (glaucoma) by preventing the production of aqueous humor. (S)-Timolol Maleate can be used for hypertension, angina pectoris and myocardial infarction[1][2][3].
n-[2-(fmoc-amino)-ethyl]glycine tert-butyl ester hydrochloride
(+/-)-4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)-benzonitrile, oxalate
Parsaclisib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EM - Phosphatidylinositol-3-kinase (pi3k) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
N,N-Dimethyl-5-({2-Methyl-6-[(5-Methylpyrazin-2-Yl)carbamoyl]-1-Benzofuran-4-Yl}oxy)pyrimidine-2-Carboxamide
Methyl N-[(4-methylphenyl)sulfonyl]glycyl-3-[amino(imino)methyl]-D-phenylalaninate
2-(6-Chloro-3-{[2,2-difluoro-2-(2-pyridinyl)ethyl]amino}-2-oxo-1(2H)-pyrazinyl)-N-[(2-fluoro-6-pyridinyl)methyl]acetamide
2-[({2-[(1Z)-3-(Dimethylamino)prop-1-enyl]-4-fluorophenyl}sulfonyl)amino]-5,6,7,8-tetrahydronaphthalene-1-carboxylic acid
N-(1H-benzimidazol-2-ylmethyl)-2-(4-morpholinyl)-9-(3-thiophenyl)-6-purinamine
N-(furan-2-ylmethylcarbamoyl)-2-[4-[(E)-2-phenylethenyl]sulfonylpiperazin-1-yl]acetamide
4,4-(3,5-Diacetoxyheptane-1,7-diyl)bispyrocatechol
Ketone, 2-ethoxy-2,4-diphenyl-2H-1-benzopyran-3-yl phenyl
N-(Tert-Butyl)-4-[5-(Pyridin-2-Ylamino)quinolin-3-Yl]benzenesulfonamide
[(2R,4aS,7aS,7bR)-3-formyl-6,6,7b-trimethyl-2,4,4a,5,7,7a-hexahydro-1H-cyclobuta[e]inden-2-yl] 3-chloro-6-hydroxy-4-methoxy-2-methylbenzoate
Ananolignan C
A lignan with a dibenzocyclooctadiene skeleton isolated from Kadsura ananosma.
(-)-(7R,7R,8S,8S)-4-hydroxy-3,3,4,5,5-pentamethoxy-7,9:7,9-diepoxylignane
A lignan that consists of tetrahydro-1H,3H-furo[3,4-c]furan substituted by 3,4,5-trimethoxyphenyl and a 4-hydroxy-3,5-dimethoxyphenyl group at positions 4 and 1 respectively. It has been isolated from the stems of Sinocalamus affinis.
4-methyl-N-[2-(phenylmethyl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]benzenesulfonamide
5-Morpholin-4-yl-9-m-tolyl-1,2,3,4-tetrahydro-9H-7-thia-6,9,11-triaza-benzo[c]fluoren-8-one
2-Phenylacetic acid [2-[4-[(4-ethoxyanilino)-oxomethyl]anilino]-2-oxoethyl] ester
N-cyclopentyl-2-[2-oxolanylmethyl-(1-oxo-2-thiophen-2-ylethyl)amino]-2-thiophen-2-ylacetamide
1-(4-amino-1,2,5-oxadiazol-3-yl)-5-methyl-N-[(E)-[4-[(3-methylphenyl)methoxy]phenyl]methylideneamino]triazole-4-carboxamide
2-[(2S,5S,6S)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]-N-(4-phenylphenyl)acetamide
(1S,2aR,8bR)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2-[oxo(3-pyridinyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1S,2aS,8bS)-N-(2-fluorophenyl)-1-(hydroxymethyl)-4-[oxo(2-pyridinyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide
(6S,7R,8S)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(2-pyrazinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(2-pyrazinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(2-pyrazinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
2-[(2S,5R,6S)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]-N-(4-phenylphenyl)acetamide
2-[(2R,5S,6R)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]-N-(4-phenylphenyl)acetamide
2-[(2R,5R,6S)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]-N-(4-phenylphenyl)acetamide
2-[(2R,5S,6S)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]-N-(4-phenylphenyl)acetamide
(1R,2aS,8bS)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2-[oxo(3-pyridinyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1S,2aS,8bS)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2-[oxo(3-pyridinyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1R,2aR,8bR)-N-(4-fluorophenyl)-1-(hydroxymethyl)-2-[oxo(3-pyridinyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide
(1S,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-4-[oxo(2-pyridinyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide
(1R,2aS,8bS)-N-(2-fluorophenyl)-1-(hydroxymethyl)-4-[oxo(2-pyridinyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide
(1R,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-4-[oxo(2-pyridinyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide
(6S,7S,8S)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(2-pyrazinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(2-pyrazinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(2-pyrazinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(2-pyrazinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(2-pyrazinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(E)-3-[5-[2-[4-[(E)-2-carboxyethenyl]-3-oxo-5-propylfuran-2-yl]propan-2-yl]-4-oxo-2-propylfuran-3-yl]prop-2-enoic acid
2-Chloro-4-[[6-[3-(3-hydroxypropylamino)propoxy]-7-methoxyquinazolin-4-yl]amino]phenol
methyl (3aR,4R,5R,6E,10E,11aR)-5-acetyloxy-10-methyl-4-[(Z)-2-methylbut-2-enoyl]oxy-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-[methyl(propyl)amino]propoxy]quinazolin-4-amine
(2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-yl 4-acetate
ML-298
ML298 is a potent and selective inhibitor of Phospholipase D2 (PLD2) with an IC50 of 355 nM. ML298 decreases invasive migration in U87-MG glioblastoma cells[1].
8-(acetyloxy)-3-[(acetyloxy)methyl]-6,10-dimethyl-2-oxo-4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl 2-methylprop-2-enoate
2-[(2s,5z)-3,6-dihydroxy-5-(2-methylpropylidene)-2h-pyrazin-2-yl]propan-2-yl 2-[(4-nitrophenyl)formamido]acetate
(3s,4s)-4-[(s)-(4-hydroxy-3,5-dimethoxyphenyl)(3,4,5-trimethoxyphenyl)methyl]-3-methyloxolan-2-one
(6r,6ar,9s,9as)-9-acetyl-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-6-methoxy-6a-methyl-6h,9h,9ah-furo[2,3-h]isochromen-8-one
(2r,3s,4s,5r,6r)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4,5-triol
(2e,4e)-5-[(1r,7s,8s,9s)-7-(acetyloxy)-4-(methoxycarbonyl)-9-methyl-11-oxo-10-oxatricyclo[6.3.2.0¹,⁷]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoic acid
1-{3-[(3-butanoyl-2,4,6-trihydroxy-5-methylphenyl)methyl]-2,4,6-trihydroxy-5-methylphenyl}butan-1-one
(2r,2ar,7s,7ar,7bs)-3-formyl-2a,4a,7-trihydroxy-6,6,7b-trimethyl-1h,2h,5h,7h,7ah-cyclobuta[e]inden-2-yl 2,4-dihydroxy-6-methylbenzoate
n-[(2r,3r,4s,5r)-1,4,5,6-tetrakis(acetyloxy)-2-[(1-hydroxyethylidene)amino]hexan-3-yl]ethanimidic acid
methyl (2s,4as,6ar,7r,9s,10as,10br)-9-(acetyloxy)-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-octahydro-1h-naphtho[2,1-c]pyran-7-carboxylate
4-[(3-butanoyl-2,4,6-trihydroxy-5-methylphenyl)methyl]-3,5-dihydroxy-6,6-dimethyl-2-propanoylcyclohexa-2,4-dien-1-one
[4-(3,4-dimethoxybenzoyl)-2-(3,4,5-trimethoxyphenyl)oxolan-3-yl]methanol
4-[(3-butanoyl-2,4-dihydroxy-6-methoxyphenyl)methyl]-3,5-dihydroxy-6,6-dimethyl-2-propanoylcyclohexa-2,4-dien-1-one
(3as,4s,4ar,7as,8s,9r,9as)-4a,8-dimethyl-3-methylidene-9-[(2-methylpropanoyl)oxy]-2,5-dioxo-3ah,4h,7ah,8h,9h,9ah-azuleno[6,5-b]furan-4-yl 2-(hydroxymethyl)prop-2-enoate
5-(acetyloxy)-1,7-bis(3,4-dihydroxyphenyl)heptan-3-yl acetate
methyl 9-(acetyloxy)-2-(furan-3-yl)-10-hydroxy-6a,10b-dimethyl-4-oxo-1h,2h,4ah,5h,6h,9h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate
(3r,4r)-4-[(s)-(3-hydroxy-4,5-dimethoxyphenyl)(3,4,5-trimethoxyphenyl)methyl]-3-methyloxolan-2-one
4-[(4-hydroxy-3,5-dimethoxyphenyl)methyl]-3-[(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one
2-[2-(3,4-dihydroxyphenyl)ethyl]tetrahydro-6-(3,4,5-trihydroxyphenyl)-2h-pyran-4-ol; (2s,4s,6s)-form,3',3''-di-me ether,4-ac
{"Ingredient_id": "HBIN003643","Ingredient_name": "2-[2-(3,4-dihydroxyphenyl)ethyl]tetrahydro-6-(3,4,5-trihydroxyphenyl)-2h-pyran-4-ol; (2s,4s,6s)-form,3',3''-di-me ether,4-ac","Alias": "NA","Ingredient_formula": "C23H28O8","Ingredient_Smile": "NA","Ingredient_weight": "432.46","OB_score": "NA","CAS_id": "182369-53-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8791","PubChem_id": "NA","DrugBank_id": "NA"}
2-c-methyl-d-erythritol1-o-β-d-(6-o-4-methoxybenzoyl)glucopyranoside
{"Ingredient_id": "HBIN005465","Ingredient_name": "2-c-methyl-d-erythritol1-o-\u03b2-d-(6-o-4-methoxybenzoyl)glucopyranoside","Alias": "NA","Ingredient_formula": "C19H28O11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14420","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(8r,8'r,9's)-5-methoxyclusin
{"Ingredient_id": "HBIN013894","Ingredient_name": "(8r,8'r,9's)-5-methoxyclusin","Alias": "NA","Ingredient_formula": "C23H28O8","Ingredient_Smile": "COC1=CC(=CC2=C1OCO2)CC3COC(C3CC4=CC(=C(C(=C4)OC)OC)OC)O","Ingredient_weight": "432.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13891","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11259008","DrugBank_id": "NA"}